William Raoofi, MD
Pain Medicine · Baltimore, MDNPI 1467846063
Payments from drug & device makers
What this record shows
13 manufacturers reported payments, led by Boston Scientific at 29.8% of the total. Reporting peaked in 2019 at $2,084 and has fallen 82.0% since, to $376 in 2025.
Across 66 payments — averaging $72.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1K
- Spinal Simplicity, LLC$1K
- Medtronic$828
- Nevro Corp.$689
- Globus Medical$353
- Abbott$222
- plus $280 from 7 others
What the payments were for
- Travel & lodging$2,45751%
- Food & beverage$2,35149%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 13 | $1,433 |
| Spinal Simplicity, LLC | 8 | $1,003 |
| Medtronic | 7 | $828 |
| Nevro Corp. | 14 | $689 |
| Globus Medical | 6 | $353 |
| Abbott | 8 | $222 |
| Vertos Medical, Inc. | 1 | $111 |
| Averitas Pharma Inc. | 2 | $45 |
| Relievant Medsystems, Inc. | 2 | $40 |
| IBSA Pharma Inc. | 2 | $33 |
| Acacia Pharma Inc | 1 | $24 |
| Avanos Medical | 1 | $14 |
| Foundation Fusion Solutions, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPECTRA WAVEWRITER$1,146
- HA MINUTEMAN G3-R$840
- RESTORE$578
- Senza$266
- Omnia$255
- INTELLIS$123
- mild Device Kit$111
How this compares
$4,808 in reported general payments places this provider in the 70th percentile of 144 pain medicine providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 147 | $2,847 |
| Pregabalin | 77 | $1,626 |
| Celecoxib | 46 | $1,159 |
| Tizanidine Hcl | 104 | $1,128 |
| Meloxicam | 112 | $510 |
| Methylprednisolone | 58 | $409 |
| Baclofen | 12 | $363 |
| Duloxetine Hcl | 12 | $243 |
| Diclofenac Sodium | 20 | $237 |
| Tramadol Hcl | 70 | $234 |
| Methocarbamol | 12 | $137 |
| Cyclobenzaprine Hcl | 19 | $131 |
| Cephalexin | 13 | $35 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Baltimore
- Randy DavisBaltimore$169K
- Paul ChristoBaltimore$137K
- Behnam JafarpourBaltimore$45K
- David MaineBaltimore$24K
- Jay KarriBaltimore$14K
- Avni GuptaBaltimore$12K
- Anuragh TrikhaBaltimore$9K
- Brian BlockBaltimore$7K
- Benjamin Fujita-HowieBaltimore$6K
- Terri BlumeBaltimore$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.